Colorectal cancer (CRC) is the third most common malignancy worldwide. CRC represents 13% of all malignant tumors and it may be expected to overcome the mortality rate of patients with heart diseases in the near future (1, 2). Approximately, one half of the population in Western countries develops a colorectal tumor by the age of 70 (3, 4). However, this type of cancer is more frequent among younger population, due to obesity, bad nutritional habits, smoking and lack of physical activity (5). Colorectal cancer develops as a polyp or adenoma in the intestinal mucosa. Malignant transformation of benign changes depends on its size and histological presentation (1). In previous years, the survival rate of patients with metastatic colorectal cancer increased significantly due to the development and the application of new chemotherapy regimens (6). There are several types of cell deaths, of which two are the main types: apoptosis and necrosis. Apoptosis, a programmed cell death, is character